Navigation Links
Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain
Date:6/30/2009

itive, the product may not prove to be safe and efficacious; Novavax's pilot plant facility is subject to extensive validation and FDA inspections, which may result in delays and increased costs; our ability to enter into future collaborations with industry partners and the government and the terms, timing and success of any such collaboration; the cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; our ability to obtain rights to technology; competition for clinical resources and patient enrollment from drug candidates in development by other companies with greater resources and visibility; our ability to obtain adequate financing in the future through product licensing, co-promotional arrangements, public or private equity or debt financing or otherwise; the maturity of the convertible notes on July 15, 2009; general business conditions; competition; business abilities and judgment of personnel; and the availability of qualified personnel. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. LMXonline Offers Spanish-Language Safety and Health Training Library
2. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
3. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
4. Sundias Animal Facility Passed Client and Government Inspection
5. PTC Therapeutics Receives $2.6 Million in Government Grants
6. Neogen Partners With Chinese Government
7. GeneNews to conduct joint project funded by MYR 5 million grant from Malaysian government
8. Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006
9. Canadian Government Announces Funding for Leading Biotechnology Firms Project
10. Mental Stimulus Package: Government Officials who Forgot to Pay Taxes Will Receive Free Memory-boosting Supplement
11. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/ -- Si... provider of vaccines, announced today that it exe...Sinovac (Dalian) Vaccine,Technology Co., Ltd. (Sin...ce,and commercialize human-use vaccines. Sinovac w...eloping and commercializing world-class vaccines; ...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...- , , ,Who: David Appia, French Ambassador for Int... Invest in France Agency, , , , ,What: Ambassador...recent pro-business initiatives adopted by France ...mic landscape for innovation and development., , ,...
(Date:11/24/2009)..., ST. LOUIS, Nov. 24 Sig...esenting at the NASDAQ OMX conference on Tuesday, ...CST. Interested parties may listen via live audio ...inve s tor.sig m a a ldrich.com/ . Users c... ,, About Sigma-Aldrich: Sigma-Aldrich is a...
(Date:11/24/2009)..., SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Sha...p; Drug Administration (SFDA) has approved the,inv...al insulin project,(Nodlin), an innovative insulin...allows Biolaxy to initiate its first phase I clini...cteristic of high blood glucose and poor,metabolis...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...IEGO, Oct. 6 Biocept, Inc. ("Biocept"), an,emergi...pointment of,Stephen M. Coutts, Ph.D. as CEO, Pres.... Dennis, Ph.D., as Director. Biocept also announc...d Director, Gordon F. Janko., "We are pleased to ...,in our field, and believe he is a good fit with o...
...IDGE, Mass. and TOKYO, Oct. 6 Galenea Corp. and,O... extension and expansion,of their research and dev...n working together since January 2005 to discover ...other central nervous system (CNS),diseases. The n... initial,five-year alliance and brings the total c...
...w Rochelle, NY, October 3, 2008Novel platform tech...driving the development of molecular diagnostics, ...s (GEN). The payoff for successful molecular diag...ormation predicts that this market currently excee...ion in four years, according to an article in the ...
Other Biology Technology:Biocept, Inc. Announces CEO and Director Appointments 2Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration 2Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration 3Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics 2
(Date:11/24/2009)...an College of Medical Toxicology (ACMT) have signe...f the Journal of Medical Toxicology (JMT), the o...10. It was previously published by the University...al Toxicology , an international, peer-reviewed jo...ractice of medical toxicology. The quarterly jour...
(Date:11/24/2009)...ble in Spanish . , The presence of increase...atory substances in the blood, hinders the loss an...ch project of the University of Navarra conducted ...hool of Pharmacy. , The project, entitled "A nut...e control of body weight and inflammation," examin...
(Date:11/23/2009)...ldlife Conservation Society says that western lowl...ic of Congopart of the "mother lode" of more than ...increasingly threatened by growing humans activity...n of the swamp forests adjacent to the southwest b...veys confirmed that high densities of the great ap...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Scientists Learn How Cancer Drugs Cause Hypertension 53768 1Scientists Learn How Cancer Drugs Cause Hypertension 53768 2George Barrett Named Chairman and CEO of Cardinal Health 53763 1George Barrett Named Chairman and CEO of Cardinal Health 53763 2George Barrett Named Chairman and CEO of Cardinal Health 53763 3George Barrett Named Chairman and CEO of Cardinal Health 53763 4Portable Health Care Records Now Available for Consumers 53759 1Portable Health Care Records Now Available for Consumers 53759 2
...w generation of pharmaceuticals are studying cellu...ind to upstream sequences of genes to turn the exp...cal companies are also hoping to develop drugs tha...actors as a way to short-circuit the harmful effec...of California, San Diego on June 16 reported new f...
...a daunting task to find a smoking gun for Darwinia... not just when and how a specific gene mutated but...real-world dominance of one population over anothe...s experiment that forced bacteria to compete in a ...oday offer the first glimpse of how individual gen...
...at it allows scientists peering inside cells to di...al protein they are studying has been developed an...oward Hughes Medical Institute,s Janelia Farm Rese...he National Institutes of Health and Florida State...e resolution of conventional optical microscopes, ...
Other Biology News:Cells use mix-and-match approach to tailor regulation of genes 2Ready, set, mutate?and may the best microbe win 2Ready, set, mutate?and may the best microbe win 3New light microscope sharpens scientists' focus 2New light microscope sharpens scientists' focus 3New light microscope sharpens scientists' focus 4New light microscope sharpens scientists' focus 5New light microscope sharpens scientists' focus 6
mitochondrial proteins (human heart) for SDS-polyacrylamide gel electrophoresis from Molecular Probes (Invitrogen)
Sentrix Custom-96 Expression Array Matrix (1) from Illumina
Primate IFN-gamma ELISpot Development Kit from R&D Systems
Rabbit Anti-Rat Heme Oxygenase-1 (2-23) Polyclonal Antibody, Unconjugated from Calbiochem
Biology Products: